Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - PRE-TAX INCOME
Pre-tax Income RGNX - REGENXBIO Inc.
-264 M
LAST VALUE
-69.31%
2 YEAR CAGR
-28.71%
5 YEAR CAGR
-47.56%
10 YEAR CAGR